Prostate Cancer
Evaluation of Recurrent Disease after Radiation Therapy for Patients Considering Local Salvage Therapy: Past vs. Contemporary Management.
December 26, 2023
What are the Most Important Objectives of Patients Undergoing Radical Prostatectomy? A Narrative Review.
December 26, 2023
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study.
December 26, 2023
Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer.
December 26, 2023
Active DHEA uptake in the prostate gland correlates with aggressive prostate cancer.
December 26, 2023
ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers.
December 26, 2023
Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer.
December 26, 2023
Blood-based liquid biopsy in advanced prostate cancer.
December 25, 2023
Incidental Discovery of Hepatocellular Carcinoma on 18F-PSMA PET CT Performed for Prostate Cancer Reassessment.
December 25, 2023
First patient dosed in Clarity’s registrational Phase III prostate cancer trial with Cu-64 SAR-bisPSMA
December 22, 2023
Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity With Unclear Benefits.
December 22, 2023
Characterizing Referrals for Prostate Cancer Genetic Services in a Safety-Net Hospital.
December 22, 2023
Real-world prevalence of homologous recombination repair mutations in advanced prostate cancer: an analysis of two clinico-genomic databases.
December 22, 2023
The PENGUIN approach to reconstruct protein interactions at enhancer-promoter regions and its application to prostate cancer.
December 22, 2023